ATECTURA BREEZHALER

novartis pharmaceuticals canada inc🇨🇦 Health Canada

Approval Id: 35cf095c23656f54
Drug Approval Canada Name: ATECTURA BREEZHALER
Product Name: ATECTURA BREEZHALER
Status: Marketed
Status Date: 2020-08-19
Original Market Date: 2020-08-19
Din: 02498707
Drug Class: Human
Dosage Form: Capsule
Route Of Administration: Inhalation
Schedule: Prescription
Ahfs: 68:04.00
Atc Original: R03AK14 INDACATEROL AND MOMETASONE
Atc Name: r 03 ak 14
Aig Number: 0262235003
Company Name: novartis pharmaceuticals canada inc
Company Address: 100, 700 Rue Saint-Hubert, Montreal, Quebec, Canada, H2Y 0C1

MOMETASONE FUROATE

160 MCG

INDACATEROL (INDACATEROL ACETATE)

150 MCG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

35cf095c23656f54

Type

Standard